Profile
Founder of Amicus Therapeutics, Inc., Orexigen Therapeutics, Inc. and Novazyme Pharmaceuticals, Inc., John Francis Crowley is Chairman & Chief Executive Officer of Amicus Therapeutics, Inc. Mr. Crowley is also on the board of 6 other companies. In the past he was Director-Business Strategy at Bristol Myers Squibb Co., President & Chief Executive Officer at Orexigen Therapeutics, Inc., President & Chief Executive Officer at Novazyme Pharmaceuticals, Inc., Litigation Associate-Health Care Practice Group at Bingham Summers Welsh & Spilman, Senior Vice President of Genzyme Therapeutics Ltd. and National Chairman at Make-A-Wish Foundation of America. He received an undergraduate degree from Georgetown University, a graduate degree from the University of Notre Dame The Law School and an MBA from Harvard Business School.
John Crowley active positions
| Companies | Position | Start |
|---|---|---|
St. Peter's University Hospital
St. Peter's University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | 23/11/2010 |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | President | - |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Director/Board Member | - |
The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Chief Executive Officer | 04/03/2024 |
Former positions of John Crowley
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Chief Executive Officer | 01/08/2022 |
| ENTRADA THERAPEUTICS, INC. | Director/Board Member | 05/12/2023 |
| INTELLIA THERAPEUTICS, INC. | Director/Board Member | 05/12/2023 |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of John Crowley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Health Technology |
Bingham Summers Welsh & Spilman
Bingham Summers Welsh & Spilman Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Novazyme Pharmaceuticals, Inc.
Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops methods for modifying recombinantly produced enzymes | Commercial Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of America
Make-A-Wish Foundation of America Miscellaneous Commercial ServicesCommercial Services Operates as a charitable organization | Commercial Services |
St. Peter's University Hospital
St. Peter's University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
The Wall Street Journal CEO Council | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Notre Dame The Law School
University of Notre Dame The Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Commercial Services |
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
- Stock Market
- Insiders
- John Crowley
















